β-Cell transplantation : a risk of insulin overproduction ?

Albert Hwa, Operations Director at the Joslin's Center for Cell-Based...

20 January, 2021

Transplanting Pancreatic Progenitors Vs Mature β-Cells

Albert Hwa, Operations Director at the Joslin's Center for Cell-Based...

20 January, 2021

Stem cell therapy for Diabetes: Type I vs Type II

Albert Hwa, Operations Director at the Joslin's Center for Cell-Based...

20 January, 2021

Cell Therapy for Diabetes : immune tolerance vs shielded strategies

Albert Hwa, Operations Director at the Joslin's Center for Cell-Based...

20 January, 2021

Stem Cell Therapy for Diabetes: Allogeneic vs Autologous ?

Albert Hwa explains why the Joslin's CCTD launched an autologous...

20 January, 2021

Stem Cell Therapy for Diabetes: Current Trials l In the Stem Cell Jungle l Albert Hwa

Albert Hwa, Operations Director at the Joslin's Center for Cell-Based...

20 January, 2021